Ultrasound vendor Esaote has chosen next month's EuroEcho-Imaging conference, to be held in Istanbul from 11 to 14 December, to highlight its Prevention Suite.
The tool combines four imaging technologies to enable preclinical assessment of cardiovascular disease risk. They include tools for quantifying coronary flow and for measuring cardiac deformation indexes, carotid intima-media thickness, and arterial stiffness, the company said.
The vascular measurements are performed using radiofrequency (RF) signal analysis, providing high spatial resolution for greater accuracy, Esaote said.
